The MHRA has released critical guidance for healthcare professionals through its updated manufacturing register. The database provides three essential functions: it maintains a comprehensive inventory of licensed production facilities, covers both human and veterinary specialist medicine manufacturers, and ensures transparency in pharmaceutical regulatory compliance across the United Kingdom.
For practicing clinicians and pharmacists, this register represents a practical resource for verifying whether facilities producing manufacturer specials—unlicensed medicines tailored to individual patient needs—hold appropriate regulatory authorization. Access to this information strengthens clinical decision-making when conventional licensed alternatives are unavailable or unsuitable for specific patients.
Understanding the register’s scope and categories enables healthcare professionals to confidently recommend specialist medicines while ensuring production facilities meet rigorous Good Manufacturing Practice standards. This transparency directly supports patient safety and quality assurance in pharmaceutical care.
Read the full article on GMJ Newsroom.
Was this article helpful?
